Juhan Reimand - Concepedia

Author

Juhan Reimand

Vrije Universiteit Amsterdam ORCID

Also Known As

Juhan Reimand, Reimand, Juhan

Publications

504

Citations

H-Index

Concepts

All Affiliations

Vrije Universiteit Amsterdam North Estonia Medical Centre Lund University Amsterdam University Medical Centers Tallinn University of Technology

About

Juhan Reimand is an author at Vrije Universiteit Amsterdam specializing in neurology, medicine, and quantitative methods.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Education	1	1	72
2	Medicine	1	1	72
3	Neurology	1	1	72
4	Neuroscience	1	1	72
5	Alzheimer's Disease	1	1	72

Juhan Reimand

Publications

497

Citations

H-Index

Page 1

	Year	Citations
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers Rik Ossenkoppele, Juhan Reimand, Ruben Smith, EMBO Molecular Medicine	2021	123
Assessing Amyloid Pathology in Cognitively Normal Subjects Using <sup>18</sup>F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods Lyduine E. Collij, Elles Konijnenberg, Juhan Reimand, Journal of Nuclear Medicine Visual AssessmentNeurodegenerative DiseasesQuantitative MethodsAlzheimer's DiseaseNeuroimaging Biomarkers	2018	72
Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent Lyduine E. Collij, Gemma Salvadó, Mahnaz Shekari, European Journal of Nuclear Medicine and Molecular Imaging	2021	64
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences Arno de Wilde, Juhan Reimand, Charlotte E. Teunissen, Alzheimer s Research & Therapy	2019	55
Association of amyloid-β CSF/PET discordance and tau load 5 years later Juhan Reimand, Lyduine E. Collij, Philip Scheltens, Neurology	2020	53
Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease Denise Visser, Emma E. Wolters, Sander C.J. Verfaillie, European Journal of Nuclear Medicine and Molecular Imaging	2020	52
Amyloid‐ <i>β</i> PET and CSF in an autopsy‐confirmed cohort Juhan Reimand, Baayla D.C. Boon, Lyduine E. Collij, Annals of Clinical and Translational Neurology	2020	33
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases Juhan Reimand, Arno de Wilde, Charlotte E. Teunissen, Alzheimer s Research & Therapy	2019	29
Why Is Amyloid-β PET Requested After Performing CSF Biomarkers? Juhan Reimand, Colin Groot, Charlotte E. Teunissen, Journal of Alzheimer s Disease	2019	16

Page 1